# Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

> **NCT06717152** · PHASE3 · COMPLETED · sponsor: **Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.** · enrollment: 427 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** SJP-0132
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06717152
- **Lead sponsor:** Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-30
- **Primary completion:** 2025-07-28
- **Final completion:** 2025-09-01
- **Target enrollment:** 427 (ACTUAL)
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717152, "Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06717152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*